Search

Your search keyword '"S. Aubin"' showing total 161 results

Search Constraints

Start Over You searched for: Author "S. Aubin" Remove constraint Author: "S. Aubin"
161 results on '"S. Aubin"'

Search Results

1. Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial

5. OC-0044 Clinical evaluation of an interactive multi-criteria optimisation workflow for HDR brachytherapy

7. OC-0101 17 years' of EBRT plus HDR brachytherapy boost in high risk localized prostate cancer patients

8. PO-0209 Practical considerations on the use of EM tracking technology for clinical HDR brachytherapy

9. 6: Ultra-Hypofractionated (UHF) Compared to Moderate-Hypofractionated (MHF) Prostate IGRT with HDR Brachytherapy Boost(BB): Four-Year Toxicities and Local Control

10. Melatonin and cortisol profiles in the absence of light perception

11. ULTRA-HYPO (UHF) Compared to Moderate-HYPO (MHF) Fractionated Prostate IGRT with HDR Brachytherapy BOOST: LONG TERM Toxicity, Acceptability and Efficiency of Delivery

12. IMAGE-Guided Brachytherapy for Primary Vaginal Cancers

13. The Impact of Dose to Bladder Neck on Urinary Toxicity in Patients Treated with HDR Brachytherapy Boost for Prostate Cancer

14. Does Delay From Prostate Cancer Diagnosis to Treatment With Permanent Seed Implantation Increase the Risk of Disease Recurrence in Men With Clinically Localized Prostate Cancer?

15. Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer

16. PD-0180: Use of 3D-ultrasound for cervical cancer brachytherapy : an imaging technique to improve contouring

17. The Risk of Second Malignancies after Seed Migration in Prostate Cancer Patients Treated With I-125 Free Seeds Brachytherapy

18. Does Large Prostate Volume Has an Impact on Biochemical Failure in Patients With Localized Prostate Cancer Treated With HDR Boost?

19. PO-0976: Hypofractionnated EBRT + HDR Brachy Boost: Lowers prostate cancer treatment burden without increasing side effects

21. Nuclear magnetic moment of 210Fr: a combined theoretical and experimental approach

23. Impulsive control for a thirteen-link biped

24. Sensor Technologies to Follow Vehicles for ITS

25. Proposed measurement of the anapole moment in francium

26. Trapping of francium for parity violation experiments

28. Does Phoenix Failure Definition Apply to EBRT + HDR Brachytherapy Boost in Prostate Cancer?

29. Impact of Implantation Technique on Biochemical Disease-free Survival in I-125 Treated Prostate Cancer Patients

30. PO-354 DOSIMETRIC IMPACTS OF UPGRADING FROM PLATO TO ONCENTRABRACHY IN A HIGH VOLUME PROSTATE HDR BRACHY-THERAPY CENTER

32. Comparison of Permanent Seed Implant Monotherapy With Combined EBRT Plus HDR Boost in Intermediate-Risk Prostate Cancer

33. Single (15 Gy) vs. 2 Fractions (of 10Gy) HDR Prostate Brachytherapy Boost: A More Practical Approach with Less Sexual Toxicity

34. Full 3D Dose Calculations for Total Body Irradiation: A Comparison Study between Treatment Planning Systems in Homogeneous and Heterogeneous Conditions

35. PD-0187: The impact of prostate volume on clinical outcomes in patients with localized prostate cancer treated with HDR boost

37. Massive isotretinoin intoxication

38. The Long-term Experience of Permanent Seed Implant Monotherapy in Low- and Intermediate-Risk Prostate Cancer

40. OC-38 BIOCHEMICAL DISEASE FREE SURVIVAL OF 3D IMAGE GUIDED BRACHYTHERAPY BOOST WITHIN A PERMANENT SEED IMPLANT

41. 705 poster DOSE VOLUME HISTOGRAMS IN PATIENTS TREATED IMAGE GUIDED SELECTIVE (DIL) HDR BOOST TO THE PROSTATE

43. 707 poster EVOLUTION OF 15 YEARS IN INVERSE PLANNED HIGH ACTIVITY I-125 SEEDS PROSTATE BRACHYTHERAPY AT L'HOTEL-DIEU DE QUEBEC: AN UPDATE ON CANCER CONTROL

44. Online image guided external beam radiation therapy for the treatment prostate cancer using electronic portal imaging: prostate motion and setup evaluation

46. 197 PROSTATE EDEMA AFTER FIDUCIAL MARKER IMPLANTATION

47. 90 poster: Does Dose Escalation to a Dominant Intraprostatic Lesion in a Permanent Implant Increase Prostate Dose Parameters?

48. The Basement Membrane Form of Heparan Sulfate Proteoglycan is Part of Human IAPP Amyloid Deposits in the Islets of Langerhans

49. [Untitled]

50. 138 Intra-operative treatment planning: A way to improve dosimetry in prostate brachytherapy

Catalog

Books, media, physical & digital resources